Pasithea Therapeutics KTTAW Ratios (2021-2026)

NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT
Reported Financials

Pasithea Therapeutics Quarterly Ratios

Periods 19 quarters
Latest Jun 2026

Pasithea Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 19 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin 5.28%-11.19%60.45%100.54%
EBT Margin -11,526.14%-19,574.36%-2,097.88%-2,126.06%
EBIT Margin -17,605.34%-22,679.43%-1,944.49%-2,110.77%
EBITDA Margin -17,605.34%-22,679.43%-1,944.49%-2,110.77%
Operating Margin -17,605.34%-22,679.43%-1,944.49%-2,110.77%
Net Margin -13,910.52%-23,024.29%-1,917.15%-3,545.60%
FCF Margin -15,771.77%-14,302.08%-2,116.61%-1,361.84%
Efficiency
Assets AverageAssets Avg. 37.18M52.20M52.05M51.32M47.39M43.61M40.10M34.40M28.39M24.26M20.04M18.15M17.35M15.36M15.83M15.32M36.94M58.30M54.03M
Invested CapitalInvested Cap. 42.51M39.40M35.72M
Asset Utilization RatioAsset Util. 0.01
Leverage & Solvency
Interest Coverage RatioInterest Cover -502.9032.67
Debt Ratio 0.000.010.00
Times Interest Earned -502.9032.67
Return Ratios
Return on Sales [ROS]ROS -17,605.34%-22,679.43%-1,944.49%-2,110.77%
Return on Capital Employed [ROCE]ROCE -12.27%-12.29%-17.05%-23.48%-32.55%-37.66%-43.24%-49.17%-62.05%-77.11%-90.79%-92.28%-87.79%-100.89%-97.57%-99.41%-65.26%-38.82%-45.90%
Return on Assets [ROA]ROA -5.85%-6.75%-11.38%-16.73%-37.46%-44.46%-49.95%-56.53%-56.46%-67.39%-82.12%-87.27%-80.14%-88.58%-84.99%-88.08%-55.31%-33.85%-39.41%